Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.22.1
Stockholders' Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended
Dec. 20, 2021
Nov. 29, 2021
Nov. 24, 2021
Jan. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Stockholders' Equity (Details) [Line Items]            
Common shares authorized (in Shares)         500,000,000  
Description of authorized capital stock         (i) 495,000,000 shares of common stock having a par value of $0.0001 per share and (ii) 5,000,000 shares of preferred stock having a par value of $0.0001 per share.   
Private placement amount       $ 1,000,000    
Sale shares (in Shares)       625,000    
Price per shares (in Dollars per share)       $ 1.6    
Shares issued (in Shares)       395,625    
Aggregate proceeds received       $ 633,000    
Issued shares (in Shares)   8,680,000        
Warrants to purchase (in Shares)   8,680,000        
Cash fee     9.00%      
Accountable expenses     $ 70,000      
Offering price per (in Dollars per share)   $ 3.5        
Aggregate gross proceeds   $ 30,380,000        
Underwriter discounts and fees   $ 27,000,000        
Warrants remain outstanding         $ 8,680,000  
Weighted average remaining life         9 years 4 months 24 days  
Aggregate intrinsic value         $ 0  
Stock based compensation         $ 96,630 $ 0
Stock option compensation (in Shares)         581,534  
Stock price per share (in Dollars per share)         $ 1.44  
Fair value of stock price exercise price (in Dollars per share)         $ 1.44  
Fair value of dividend yield percentage         0.00%  
Fair value of expected term         6 years  
Fair value of volatility         50.50%  
Fair value of risk-free interest rate         1.44%  
Stock option granted price (in Dollars per share)          
Minimum [Member]            
Stockholders' Equity (Details) [Line Items]            
Investors election percentage         4.99%  
Maximum [Member]            
Stockholders' Equity (Details) [Line Items]            
Investors election percentage         9.99%  
Second Private Placement [Member]            
Stockholders' Equity (Details) [Line Items]            
Private placement amount           $ 5,000,000
Sale shares (in Shares)           2,083,333
Price per shares (in Dollars per share)           $ 2.4
Shares issued (in Shares)           239,969
Aggregate proceeds received           $ 576,000
RSUs [Member]            
Stockholders' Equity (Details) [Line Items]            
Stock based compensation         $ 24,000 0
Stock option compensation (in Shares)         264,000  
Stock option granted (in Shares) 200,000          
Stock option granted price (in Dollars per share) $ 1.44          
Restricted Stock [Member]            
Stockholders' Equity (Details) [Line Items]            
Stock based compensation         $ 15,000 $ 0
Dr. Marques [Member]            
Stockholders' Equity (Details) [Line Items]            
Stock option granted (in Shares) 200,000          
Fair value of stock options granted (in Dollars per share) $ 0.7          
November 2021 Private Placement [Member]            
Stockholders' Equity (Details) [Line Items]            
Issued shares (in Shares)     8,680,000      
Warrants to purchase (in Shares)     8,680,000      
Shares of common stock (in Shares)     8,680,000      
Purchase price (in Dollars per share)     $ 3.5      
Warrants term     5 years      
Exercise per share (in Dollars per share)     $ 3.5      
Cash fee     1.00%